A detailed history of Oxler Private Wealth LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Oxler Private Wealth LLC holds 16,671 shares of ABBV stock, worth $3 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
16,671
Previous 16,538 0.8%
Holding current value
$3 Million
Previous $2.84 Million 16.08%
% of portfolio
1.22%
Previous 1.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $21,790 - $26,510
133 Added 0.8%
16,671 $3.29 Million
Q2 2024

Jul 29, 2024

BUY
$154.79 - $180.76 $24,456 - $28,560
158 Added 0.96%
16,538 $2.84 Million
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $2.1 Million - $2.39 Million
13,122 Added 402.76%
16,380 $2.98 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $1.76 Million - $1.98 Million
-12,788 Reduced 79.7%
3,258 $504,000
Q3 2023

Oct 12, 2023

BUY
$133.59 - $154.65 $18,969 - $21,960
142 Added 0.89%
16,046 $2.39 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $5,565 - $6,925
-42 Reduced 0.26%
15,904 $2.14 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $21,836 - $25,147
151 Added 0.96%
15,946 $2.54 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $2.18 Million - $2.62 Million
15,795 New
15,795 $2.55 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $20,505 - $26,069
149 Added 0.97%
15,495 $2.37 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $19,533 - $24,235
148 Added 0.97%
15,346 $2.49 Million
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $457,587 - $503,749
4,473 Added 41.71%
15,198 $1.64 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $863,255 - $1.17 Million
10,725 New
10,725 $1.15 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Oxler Private Wealth LLC Portfolio

Follow Oxler Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxler Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxler Private Wealth LLC with notifications on news.